ITCSX
Price
$29.39
Change
-$0.22 (-0.74%)
Updated
Jun 13 closing price
Net Assets
6.69B
RLBCX
Price
$35.41
Change
-$0.31 (-0.87%)
Updated
Jun 13 closing price
Net Assets
244.39B
Interact to see
Advertisement

ITCSX vs RLBCX

Header iconITCSX vs RLBCX Comparison
Open Charts ITCSX vs RLBCXBanner chart's image
VY® T. Rowe Price Capital Apprec S
Price$29.39
Change-$0.22 (-0.74%)
VolumeN/A
Net Assets6.69B
American Funds American Balanced R3
Price$35.41
Change-$0.31 (-0.87%)
VolumeN/A
Net Assets244.39B
ITCSX vs RLBCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ITCSX vs. RLBCX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ITCSX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 244B vs. ITCSX (6.69B). ITCSX pays higher dividends than RLBCX: ITCSX (2.44) vs RLBCX (1.63). ITCSX was incepted earlier than RLBCX: ITCSX (36 years) vs RLBCX (23 years). ITCSX (0.90) and RLBCX (0.89) have similar cost to investors . ITCSX is a more actively managed with annual turnover of: 84.00 vs. RLBCX (44.00). ITCSX has a lower initial minimum investment than RLBCX: ITCSX (0) vs RLBCX (250). ITCSX annual gain was more profitable for investors over the last year : 8.62 vs. RLBCX (4.94). RLBCX return over 5 years is better than : 36.51 vs. ITCSX (8.29).
ITCSXRLBCXITCSX / RLBCX
Total Expense Ratio0.900.89101%
Annual Report Gross Expense Ratio0.900.89101%
Fund Existence36 years23 years-
Gain YTD3.9624.29492%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets6.69B244B3%
Annual Yield % from dividends2.441.63149%
Returns for 1 year8.624.94174%
Returns for 3 years11.8431.5438%
Returns for 5 years8.2936.5123%
Returns for 10 years14.0254.9925%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLTX44.210.19
+0.43%
MoonLake Immunotherapeutics
NOVA0.22N/A
N/A
Sunnova Energy International
XTNT0.62-0.03
-4.23%
Xtant Medical Holdings
FND73.63-3.40
-4.41%
Floor & Decor Holdings
EZGO0.36-0.02
-4.65%
EZGO Technologies Ltd